Evidence map›Paper›PMID 21439477›Full record

ArticleChemistry & biology2011

Novel ligands for a purine riboswitch discovered by RNA-ligand docking.

Peter Daldrop, Francis E Reyes, David A Robinson, Colin M Hammond, David M Lilley, Robert T Batey, Ruth Brenk

Abstract read
In one paragraph

Article in Chemistry & biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Comparative Evaluation of Explicit Solvent Models for RNA-Ligand Docking.Journal of chemical information and modeling · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. ACS chemical biology · 2023
    Article
  11. Fragment-Based Approaches to Identify RNA Binders.Journal of medicinal chemistry · 2023
    Review
  12. RNA 3D Modeling with FARFAR2, Online.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Mining for Ligandable Cavities in RNA.ACS medicinal chemistry letters · 2021
    Article
  18. Riboswitches as Drug Targets for Antibiotics.Antibiotics (Basel, Switzerland) · 2021
    Review
  19. RLDOCK: A New Method for Predicting RNA-Ligand Interactions.Journal of chemical theory and computation · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Peter DaldropDivision of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, UK.
Francis E Reyes
David A Robinson
Colin M Hammond
David M Lilley
Robert T Batey
Ruth Brenk

Funding

Basis of Gene Regulation by Purine-Binding mRNAsR01GM073850 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI BATEY, ROBERT T · 2005 to 2022
$4.8M
Cancer Research UK 11722NIGMS NIH HHS GM-073850NIGMS NIH HHS R01 GM073850Wellcome Trust 083930/Z/07/ZWellcome Trust 089691/Z/09/ZWellcome Trust WT083481
6 · The paper itself

Abstract

The increasing number of RNA crystal structures enables a structure-based approach to the discovery of new RNA-binding ligands. To develop the poorly explored area of RNA-ligand docking, we have conducted a virtual screening exercise for a purine riboswitch to probe the strengths and weaknesses of RNA-ligand docking. Using a standard protein-ligand docking program with only minor modifications, four new ligands with binding affinities in the micromolar range were identified, including two compounds based on molecular scaffolds not resembling known ligands. RNA-ligand docking performed comparably to protein-ligand docking indicating that this approach is a promising option to explore the wealth of RNA structures for structure-based ligand design.

Indexed as

LigandsRiboswitchBinding SitesComputer SimulationCrystallography, X-RayNucleic Acid ConformationPurinesRNALigandspurinePurinesRiboswitchRNA

Identifiers

PMID21439477
PMCPMC3119931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.